Literature DB >> 2251282

Preferential binding of growth inhibitory prostaglandins by the target protein of a carcinogen.

S H Khan1, S Sorof.   

Abstract

Liver fatty acid binding protein (L-FABP) is the principal target protein of the hepatic carcinogen N-(2-fluorenyl)acetamide (2-acetylaminofluorene) in rat liver. In addition, the cyclopentenone prostaglandins (PG), PGA, PGJ2, and delta 12-PGJ2, inhibit the growth of many cell types in vitro. This report describes the preferential binding of the growth inhibitory prostaglandins by L-FABP and the reversible inhibition of thymidine incorporation into DNA by PGA2 and delta 12-PGJ2 in primary cultures of purified rat hepatocytes. As a model ligand, [3H]PGA1 bound to L-FABP specifically, reversibly, rapidly, and with high affinity. Its dissociation constants were 134 nM (high affinity) and 3.6 microM (low affinity). The high-affinity binding of [3H]PGA1 was 9- and approximately 13-fold more avid than the binding of the conventional fatty acid ligands, oleic acid and arachidonic acid, respectively. The abilities of different prostaglandins to compete with the high-affinity binding of [3H]PGA1 correlated with their growth inhibitory activities reported previously and here. The growth inhibitory cyclopentenone prostaglandins (PGA1, PGA2, delta 12-PGJ2, and PGJ2) were the best competitive ligands, intermediate competitors were the weak growth inhibitors PGE1 and PGD2, and the poorest competitors were PGE2 and PGF2 alpha, which stimulate rather than inhibit DNA synthesis in rat hepatocytes in primary culture. The in vitro actions of L-FABP are compatible with those of a specific and dissociable carrier of growth inhibitory prostaglandins in rat hepatocytes and suggest that the carcinogen may usurp the cellular machinery of the growth inhibitory prostaglandins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2251282      PMCID: PMC55173          DOI: 10.1073/pnas.87.23.9401

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Site and mechanism of growth inhibition by prostaglandins. IV. Effect of cyclopentenone prostaglandins on cell cycle progression of G1-enriched HeLa S3 cells.

Authors:  K Ohno; T Sakai; M Fukushima; S Narumiya; M Fujiwara
Journal:  J Pharmacol Exp Ther       Date:  1988-04       Impact factor: 4.030

2.  A low-molecular-weight protein from rat liver that resembles ligandin in its binding properties.

Authors:  B Ketterer; E Tipping; J F Hackney; D Beale
Journal:  Biochem J       Date:  1976-06-01       Impact factor: 3.857

3.  Inhibition of DNA synthesis and cell cycle by prostaglandins independent of cyclic AMP.

Authors:  M Hughes-Fulford; J Wu; T Kato; M Fukushima
Journal:  Adv Prostaglandin Thromboxane Leukot Res       Date:  1985

Review 4.  Functions of fatty acid binding proteins.

Authors:  R M Kaikaus; N M Bass; R K Ockner
Journal:  Experientia       Date:  1990-06-15

5.  Endogenous prostaglandin as (PGAs): fact or artifact in biological systems.

Authors:  H T Jonsson; R E Powers
Journal:  Prog Lipid Res       Date:  1981       Impact factor: 16.195

6.  Specific high affinity binding of lipoxygenase metabolites of arachidonic acid by liver fatty acid binding protein.

Authors:  H Raza; J R Pongubala; S Sorof
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

7.  Occurrence of 9-deoxy-delta 9,delta 12-13,14-dihydroprostaglandin D2 in human urine.

Authors:  Y Hirata; H Hayashi; S Ito; Y Kikawa; M Ishibashi; M Sudo; H Miyazaki; M Fukushima; S Narumiya; O Hayaishi
Journal:  J Biol Chem       Date:  1988-11-15       Impact factor: 5.157

8.  Metabolic dehydration of prostaglandin E2 and cellular uptake of the dehydration product: correlation with prostaglandin E2-induced growth inhibition.

Authors:  K Ohno; M Fujiwara; M Fukushima; S Narumiya
Journal:  Biochem Biophys Res Commun       Date:  1986-09-14       Impact factor: 3.575

9.  Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition.

Authors:  S Narumiya; M Fukushima
Journal:  J Pharmacol Exp Ther       Date:  1986-11       Impact factor: 4.030

10.  Requirement of a reactive alpha, beta-unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by "A" series prostaglandins.

Authors:  K V Honn; L J Marnett
Journal:  Biochem Biophys Res Commun       Date:  1985-05-31       Impact factor: 3.575

View more
  18 in total

Review 1.  Liver fatty acid-binding protein and obesity.

Authors:  Barbara P Atshaves; Gregory G Martin; Heather A Hostetler; Avery L McIntosh; Ann B Kier; Friedhelm Schroeder
Journal:  J Nutr Biochem       Date:  2010-11       Impact factor: 6.048

Review 2.  The organization and consequences of eicosanoid signaling.

Authors:  Roy J Soberman; Peter Christmas
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

3.  Specific growth stimulation by linoleic acid in hepatoma cell lines transfected with the target protein of a liver carcinogen.

Authors:  T Keler; C S Barker; S Sorof
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

4.  Antiproliferative prostaglandins activate heat shock transcription factor.

Authors:  C Amici; L Sistonen; M G Santoro; R I Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

5.  Liver fatty acid-binding protein: specific mediator of the mitogenesis induced by two classes of carcinogenic peroxisome proliferators.

Authors:  S H Khan; S Sorof
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

Review 6.  Cellular binding proteins for fatty acids and retinoids: similar or specialized functions?

Authors:  N M Bass
Journal:  Mol Cell Biochem       Date:  1993 Jun 9-23       Impact factor: 3.396

Review 7.  Modulation of mitogenesis by liver fatty acid binding protein.

Authors:  S Sorof
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

8.  Selective inhibition of virus protein synthesis by prostaglandin A1: a translational block associated with HSP70 synthesis.

Authors:  C Amici; C Giorgi; A Rossi; M G Santoro
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

9.  Purification and characterization of a fatty acid binding protein from human prostatic tissue.

Authors:  A A Chaudry; A K Dutta-Roy
Journal:  Lipids       Date:  1993-05       Impact factor: 1.880

10.  Expression in Escherichia coli and characterization of the fatty-acid-binding protein from human muscle.

Authors:  R A Peeters; J M Ena; J H Veerkamp
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.